WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals
World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

ISSN 2457-0400

Impact Factor  :  5.464

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • WJAHR New Impact Factor

    Its our Pleasure to Inform you that WJAHR Impact Factor has been increased from  4.897 to 5.464 due to high quality Publication at International Level

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2021 Issue has been successfully launched on 1 November 2021

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR 1 November 2021 Issue has been Published, Kindly check it on http://www.wjahr.com/home/current_issues

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

IN SILICO PREDICTION OF THE MECHANISM OF LEVETIRACETAM AGAINST ALZHEIMER’S DISEASE

Zarmina Khan, Tahir Ali Chohan, Ghulam Murtaza, Sidra Khan and Sajjad Haider*

ABSTRACT

Objective: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that is affecting people worldwide and it is important to discover effective drug treatment for Alzheimer’s disease. Levetiracetam (LEV) is an anticonvulsive drug use in epilepsy and found effective in treatment of Alzheimer’s disease but the mode of action of LEV against AD is unclear. So, this study aims to explore the anti-AD mechanism of LEV. Methods: A database named STITCH was used to identify the targets of LEV and a protein-protein interaction network was constructed using the same database which evaluated the interaction between the targets. Furthermore, gene ontology enrichment analysis with ClueGO plugin was used. Finally docking was performed for computational analysis. Results: According to results shown, 48 drug targets or gene proteins were found. After analyzing these targets abundance values and by gene functional annotation, seven GO terms were found to be closely related with Alzheimer’s disease. The terms found to be involved in mechanism of LEV against AD are KCNMA1, CBS, GRIN2B, CSTB, APOD, AMPH and FAS. Conclusions: The findings elaborate that LEV can be utilized to manage AD. However, multiple molecular mechanisms of action could be proposed for this effect. The observed core anti-AD mechanism of LEV could be the action on different genes found to be involved in AD. Furthermore, ILE97 and ALA436 are found to be interactive towards LEV. These mechanisms can be further elaborated through in-vivo studies.

[Full Text Article]